Skip to main content
U.S. flag

An official website of the United States government

Rivastigmine tartrate

Published by U.S. Food and Drug Administration | U.S. Department of Health & Human Services | Catalog Last Checked: September 10, 2026 at 07:50 PM | Dataset Last Updated: March 17, 2025
Rivastigmine Tartrate is a generic prescription medication available as oral capsules in strengths of 1.5mg, 3mg, 4.5mg, and 6mg (base equivalent). It acts as a cholinesterase inhibitor to help manage symptoms of Alzheimer's disease and related dementias. Manufactured by Macleods Pharmaceuticals Limited. This information was generated using AI and is provided for informational and research purposes only.

Resources

1 resource available

Find Related Datasets

Search by Tags

Click any tag below to search for similar datasets